Dr. Genqing Liang is a well-regarded scientist whose research focuses on molecular genetics and immunology. Dr. Liang excels in experimental planning and assay development as well as novel project development. In this capacity, he has joined the Health Studies Collegium as a Fellow. In conjunction with Dr Liang’s many credits, his work is widely published. Amongst the numerous scientific and academic journals he can be found cited in are the Journal of Allergy and Clinical Immunology, Nature, The Journal of Biological Chemistry, and Human Molecular Genetics. While a Research Fellow at the National Institute of Health, Dr. Liang focused specifically on molecular immunology and investigated genome-wide regulation of c-myc-Igh-mediated cancer development: This included using chip-sequencing, in vitro assays and an in vivo mouse model. His research also examined inhibition in breast cancer by a small molecule RGS16 (regulator of G protein signaling), using drug treatment assay, proliferation assay, confocal microscopy, and biochemical/molecular techniques. While a Visiting Scientist at the University of Sydney – Australia, Dr. Liang’s research investigated the function of proteinase K in cell structure, using biochemical techniques and confocal microscopy.
Dr. Liang was awarded his Ph.D. in Molecular/Cellular Biology and Genetics from the University of Guelph, Canada. He also holds an M.S. in Genetics, from China Agricultural University, and a B.S. in Biology, from Hebei Agricultural University in China. In addition, Dr. Liang is a member of both the American Academy of Allergy Asthma Immunology and the American Society of Nephrology.
Click here for a list of publications and invited presentations.
